On February 18, 2020, the Board of Directors of Amneal Pharmaceuticals, Inc. appointed, effective immediately, Paul M. Meister to the Board's Compensation Committee and Nominating and Corporate Governance Committee and the Board's newly formed Technology and Operational Compliance Committee.